Reference #: 00718
The University of South Carolina is offering licensing opportunities for an exciting advancement in cancer treatment. Fusarochromanone is a photodynamic therapy that targets cancer cells without destroying healthy cells. It is effective in low doses and has limited side effects.
Potential Applications:
Fusarochromanone can be used in the treatment of a variety of cancers.
Advantages and Benefits:
Background:
Cancer is the leading cause of death worldwide, and is estimated to cost over $226 billion annually. Moreover, traditional cancer treatments carry the risk of severe, life altering side effects for the patient as they destroy healthy cells with cancer cells.
Invention Description:
Fusarochromanone (FC101) is a fluorescent anti-cancer therapy. FC101 accumulates more rapidly in tumor cells than in normal cells. When exposed to light, FC101 produces a reactive oxygen species that kills the tumor cells but leaves the normal cells intact. FC101 can be administered locally and in low does to limit side effects.